Kidtrayze

Zinc chloride, the active ingredient in Kidtrayze, is a trace element supplement presented as a solution for injection for intravenous use. It provides essential trace elements required for enzymatic activity and metabolic processes when administered intravenously, supporting growth and antioxidant defenses in patients receiving parenteral nutrition.\n\nGNH India supplies Kidtrayze as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kidtrayze is a trace element solution used to address deficiencies in patients receiving parenteral nutrition.\n\n- Total parenteral nutrition (TPN): supplementation of essential trace elements to prevent deficiency.\n- Premature infants: provision of zinc, copper, selenium, manganese, and iodine to support growth and development.\n- Critically ill patients: maintenance of trace element status during intensive care.\n- Renal replacement therapy patients: replacement of trace elements lost during dialysis.

Kidtrayze may be associated with adverse reactions following intravenous administration.\n\nCommon Side Effects:\n- Injection site pain or erythema.\n- Transient mild nausea.\n- Temporary elevation of serum sodium levels.\n\nSerious or Rare Side Effects:\n- Anaphylactic or severe hypersensitivity reaction.\n- Copper toxicity presenting with hepatic dysfunction.\n- Selenium excess leading to selenosis (e.g., hair loss, nail changes).

Kidtrayze requires careful monitoring in specific clinical situations.\n\n- Renal impairment: monitor serum trace element concentrations and adjust dosing.\n- Liver disease: use with caution due to altered metabolism of copper and manganese.\n- Pregnancy: safety not established; weigh potential benefits against risks.\n- Concurrent parenteral nutrition: avoid duplicate supplementation of trace elements.\n- Known hypersensitivity: discontinue immediately if allergic reaction occurs.\n- Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Kidtrayze can interact with other agents that affect trace element balance.\n\nMajor Interactions (Avoid):\n- Copper‑containing solutions: risk of precipitation and reduced efficacy.\n- High‑dose zinc supplements: may inhibit copper absorption leading to deficiency.\n- Additional selenium preparations: increase risk of selenium toxicity.\n\nModerate Interactions (Monitor Closely):\n- Thyroid hormone therapy: iodine content may influence hormone levels.\n- Antioxidant vitamins (C/E): may modify selenium activity.\n- Renal replacement therapy: altered clearance of administered trace elements.